State of Wyoming’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

State of Wyoming’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-111,527	Closed	-$46.8K	–	2007
2025 Q4	$46.8K	Buy	+111,527	New	+$59.1K	0.01%	1569
2024 Q2	–	Sell	-75,319	Closed	-$50.5K	–	1858
2024 Q1	$50.5K	Sell	75,319 -77,655	-51%	-$56.3K	0.01%	1286
2023 Q4	$83.1K	Buy	152,974 +60,614	+66%	+$27.9K	0.02%	1124
2023 Q3	$55.4K	Buy	+92,360	New	+$98.9K	0.01%	1219
2021 Q3	–	Sell	-36	Closed	–	–	1324
2021 Q2	$0	Buy	36 +2	+6%	+$23	﹤0.01%	1216
2021 Q1	$0	Buy	+34	New	+$458	﹤0.01%	543

Other funds holding SGMO

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State of Wyoming's SGMO Position: Q1 2026 in Review

State of Wyoming sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2026, closing a stake of 111,527 shares — an estimated $46.8K sold.

State of Wyoming first reported a position in SGMO in Q1 2021 and held it in 6 quarters. The position peaked at $83.1K in Q4 2023. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

State of Wyoming reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2026 after selling out during the quarter.
State of Wyoming sold 111,527 SANGAMO THERAPEUTICS INC shares in Q1 2026, an estimated $46.8K.
State of Wyoming first reported a position in SANGAMO THERAPEUTICS INC in Q1 2021 and held it in 6 quarters.
State of Wyoming's SANGAMO THERAPEUTICS INC position peaked at $83.1K in Q4 2023.
112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.